Novavax on Wednesday raised its full-year revenue forecast as it received a $175 million milestone payment from Sanofi ...

The decision will impact 22 projects speerheaded by major pharmaceutical companies for vaccines against bird flu and other ...

Kennedy said Tuesday that the terminated contracts were worth nearly $500 million. Among them is an award to the University ...

Novavax raised its full-year adjusted revenue forecast on Wednesday, banking on higher sales tied to its vaccine supply ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the second quarter ended ...

Most life-years saved were among people aged 60 years or older; estimates are more conservative than those that focused on the first year of vaccination ...

The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...

T he U.S. Department of Health and Human Services (HHS) said on Tuesday that it will start winding down mRNA vaccine ...

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

Researchers at the University of New Mexico are preparing to launch a phase 1 clinical trial for an Alzheimer's vaccine after ...